Similar articles

• Insulin-like growth factor-I and risk of breast cancer.

  Janssen JA, Lamberts SW. Janssen JA, et al. Lancet. 1998 Aug 8;352(9126):490. doi: 10.1016/s0140-6736(05)79230-8. Lancet. 1998. PMID: 9708785 No abstract available.
• Insulin-like growth factor-I and risk of breast cancer.

  Campagnoli C, Ambroggio S, Biglia N, Peris C, Sismondi P. Campagnoli C, et al. Lancet. 1998 Aug 8;352(9126):488-9. doi: 10.1016/s0140-6736(05)79226-6. Lancet. 1998. PMID: 9708782 No abstract available.
• Effects of alcohol and menstrual cycle on insulin-like growth factor-I and insulin-like growth factor binding protein-3.

  Lavigne JA, Wimbrow HH, Clevidence BA, Albert PS, Reichman ME, Campbell WS, Barrett JC, Hursting SD, Judd JT, Taylor PR. Lavigne JA, et al. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2264-7. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598790 Clinical Trial.
• Obesity and breast cancer in premenopausal women: Current evidence and future perspectives.

  Laudisio D, Muscogiuri G, Barrea L, Savastano S, Colao A. Laudisio D, et al. Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:217-221. doi: 10.1016/j.ejogrb.2018.03.050. Epub 2018 Mar 27. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29730021 Review.
• Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature.

  Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K. Sugumar A, et al. Int J Cancer. 2004 Aug 20;111(2):293-7. doi: 10.1002/ijc.20253. Int J Cancer. 2004. PMID: 15197785